LSIPR 50 2018: Sandy Macrae

02-08-2018

Sandy Macrae was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.

sandymacrae_sangamo.jpg

 

 


Sandy Macrae, LSIPR 50 2018, Sangamo Therapeutics, genome-editing therapeutic, zinc finger proteing technology, biopharmaceuticals, Pfizer, Kite-Gilead

LSIPR